EAM
Erste Asset Management Portfolio holdings
AUM
$11.9B
1-Year Return
22.95%
This Quarter Return
+19.85%
1 Year Return
+22.95%
3 Year Return
+112.82%
5 Year Return
+205.55%
10 Year Return
–
AUM
$1.79B
AUM Growth
+$298M
(+20%)
Cap. Flow
+$52.5M
Cap. Flow
% of AUM
2.94%
Top 10 Holdings %
Top 10 Hldgs %
26.42%
Holding
1,026
New
21
Increased
130
Reduced
91
Closed
43
Top Buys
| 1 |
AMRN
Amarin Corp
AMRN
|
$37.6M |
| 2 |
CELG
Celgene Corp
CELG
|
$21.2M |
| 3 |
Gilead Sciences
GILD
|
$9.48M |
| 4 |
Biogen
BIIB
|
$7.32M |
| 5 |
Intuitive Surgical
ISRG
|
$5.87M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
$24.5M |
| 2 |
Meta Platforms (Facebook)
META
|
$8.82M |
| 3 |
ATVI
Activision Blizzard Inc.
ATVI
|
$7.92M |
| 4 |
VF Corp
VFC
|
$5.23M |
| 5 |
Erie Indemnity
ERIE
|
$5M |
Sector Composition
| 1 | Healthcare | 33.37% |
| 2 | Technology | 20.44% |
| 3 | Consumer Discretionary | 12.16% |
| 4 | Financials | 8.69% |
| 5 | Communication Services | 6.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Sysco
SYY
$39.5B
| $1.13M | 0.06% |
17,010
-5,980
| -26% | -$396K |
|
227
Western Union
WU
$2.82B
| $1.12M | 0.06% |
+60,000
| New | +$1.12M |
|
228
American International
AIG
$45.3B
| $1.08M | 0.06% |
25,000
| – | – |
|
229
Altria Group
MO
$112B
| $1.06M | 0.06% |
18,760
-42,073
| -69% | -$2.39M |
|
230
Netflix
NFLX
$534B
| $1.06M | 0.06% |
+3,000
| New | +$1.06M |
|
231
Q32 Bio
QTTB
$20.2M
| $1.06M | 0.06% |
+2,111
| New | +$1.06M |
|
232
MillerKnoll
MLKN
$1.45B
| $1.05M | 0.06% |
30,000
| – | – |
|
233
Agnico Eagle Mines
AEM
$74.5B
| $1.05M | 0.06% |
24,000
+1,400
| +6% | +$61.2K |
|
234
Grifois
GRFS
$6.74B
| $1.02M | 0.06% |
53,456
| – | – |
|
235
Gildan
GIL
$8.21B
| $1.01M | 0.06% |
28,100
| – | – |
|
236
Synopsys
SNPS
$111B
| $997K | 0.06% |
8,850
-16,910
| -66% | -$1.9M |
|
237
Etsy
ETSY
$5.17B
| $956K | 0.05% |
14,600
+6,900
| +90% | +$452K |
|
238
Automatic Data Processing
ADP
$122B
| $950K | 0.05% |
6,000
| – | – |
|
239
Denali Therapeutics
DNLI
$2.16B
| $944K | 0.05% |
42,200
+29,000
| +220% | +$649K |
|
240
ConocoPhillips
COP
$120B
| $943K | 0.05% |
14,000
| – | – |
|
241
MetLife
MET
$54.4B
| $934K | 0.05% |
22,000
-10,000
| -31% | -$425K |
|
242
CDW
CDW
$21.8B
| $929K | 0.05% |
9,755
+100
| +1% | +$9.52K |
|
243
TAL Education Group
TAL
$6.24B
| $893K | 0.05% |
25,000
| – | – |
|
244
Credicorp
BAP
$20.6B
| $892K | 0.05% |
3,732
+568
| +18% | +$136K |
|
245
Ligand Pharmaceuticals
LGND
$3.27B
| $889K | 0.05% |
11,542
| – | – |
|
|
JKS
246
JinkoSolar
JKS
$1.25B
| $881K | 0.05% |
+50,000
| New | +$881K |
|
|
GHDX
247
DELISTED
Genomic Health, Inc.
GHDX
| $857K | 0.05% |
12,400
| – | – |
|
248
Veeco
VECO
$1.44B
| $838K | 0.05% |
80,000
| – | – |
|
|
BLDP
249
Ballard Power Systems
BLDP
$556M
| $828K | 0.05% |
275,000
| – | – |
|
250
Travere Therapeutics
TVTX
$1.89B
| $820K | 0.05% |
35,600
-8,400
| -19% | -$193K |
|